AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
56.69
-2.57 (-4.34%)
At close: Aug 20, 2026, 4:00 PM EDT
57.71
+1.02 (1.80%)
Pre-market: Aug 21, 2026, 5:01 AM EDT
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.68 billion as of August 20, 2026. Its market cap has increased by 202.92% in one year.
Market Cap
1.68B
Enterprise Value
1.67B
1-Year Change
202.92%
Ranking
Category
Stock Price
$56.69
ChartMarket Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.68B, an increase of 443.73%. That is a compound annual growth rate of 19.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 1.65B | 22.90% |
| Dec 31, 2025 | 1.34B | 233.16% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Recursion Pharmaceuticals | 1.88B |
| Maravai LifeSciences Holdings | 1.87B |
| Intellia Therapeutics | 1.86B |
| Braveheart Bio | 1.86B |
| Syndax Pharmaceuticals | 1.85B |
| Avalyn Pharma | 1.73B |
| Fortrea Holdings | 1.73B |
| Absci | 1.71B |